Galectin 7 (p53-Induced Gene 1): A New Prognostic Predictor of Recurrence and Survival in Stage IV Hypopharyngeal Cancer
- 23 May 2006
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 13 (7), 999-1009
- https://doi.org/10.1245/aso.2006.08.033
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Galectin-7Cellular and Molecular Life Sciences, 2006
- Profiling early head and neck cancerNature Reviews Cancer, 2005
- Galectins as modulators of tumour progressionNature Reviews Cancer, 2005
- Head and Neck CancerCancer Research, 2004
- Chemical Biology of the Sugar CodeChemBioChem, 2004
- Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and NeckThe New England Journal of Medicine, 2004
- Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck CancerThe New England Journal of Medicine, 2004
- Galectins and cancerBiochimica et Biophysica Acta (BBA) - General Subjects, 2002
- The use of biological therapy in cancer of the head and neck.Current Problems in Cancer, 1999
- A model for p53-induced apoptosisNature, 1997